These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25449054)

  • 1. Drug analysis of residual content of used syringes: a new approach for improving knowledge of injected drugs and drug user practices.
    Néfau T; Charpentier E; Elyasmino N; Duplessy-Garson C; Levi Y; Karolak S
    Int J Drug Policy; 2015 Apr; 26(4):412-9. PubMed ID: 25449054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug residues in used syringes in Switzerland: A comparative study.
    Lefrançois E; Augsburger M; Esseiva P
    Drug Test Anal; 2018 May; 10(5):874-879. PubMed ID: 29111580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of residual content of used syringes collected from low threshold facilities in Lausanne, Switzerland.
    Lefrançois E; Esseiva P; Gervasoni JP; Lucia S; Zobel F; Augsburger M
    Forensic Sci Int; 2016 Sep; 266():534-540. PubMed ID: 27514014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE).
    Brunt TM; Lefrançois E; Gunnar T; Arponen A; Seyler T; Goudriaan AE; McAuley A; McKeown DA; Detrez V; Csorba J; Deimel D; Auwärter V; Kempf J; Karolak S; Nefau T
    Int J Drug Policy; 2021 Sep; 95():103130. PubMed ID: 33487529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substances injected at the Sydney supervised injecting facility: A chemical analysis of used injecting equipment and comparison with self-reported drug type.
    Lefrancois E; Belackova V; Silins E; Latimer J; Jauncey M; Shimmon R; Mozaner Bordin D; Augsburger M; Esseiva P; Roux C; Morelato M
    Drug Alcohol Depend; 2020 Apr; 209():107909. PubMed ID: 32145660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical findings in used syringes from a syringe exchange program.
    Fiorentin TR; Logan BK
    Int J Drug Policy; 2020 Jul; 81():102770. PubMed ID: 32442881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. More free syringes, fewer drug injectors in the case of Spain.
    Bravo MJ; Royuela L; Barrio G; de la Fuente L; Suarez M; Teresa Brugal M
    Soc Sci Med; 2007 Oct; 65(8):1773-8. PubMed ID: 17658207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of drugs and hepatitis C virus in used syringes from a needle exchange in Gothenburg, Sweden.
    Bergström MA; Andersson ME; Larsson SB
    Drug Test Anal; 2024 Sep; 16(9):948-956. PubMed ID: 38044807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of injecting drug uses and HIV-1 infection: analysis from needle exchange program.
    Tellado I; Moran N; Vargas Vidot J; Yamamura Y
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1091-6. PubMed ID: 9449543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges.
    Miller CL; Tyndall M; Spittal P; Li K; Palepu A; Schechter MT
    J Urban Health; 2002 Jun; 79(2):257-65. PubMed ID: 12023501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Which psychoactives substances are found in used syringes?].
    Nordmann S; Nefau T; Micallef J; Duplessy C; Catusse JC; Frauger E
    Therapie; 2023; 78(5S):S51-S57. PubMed ID: 27771105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changing patterns of first injection across key periods of the French Harm Reduction Policy: PrimInject, a cross sectional analysis.
    Guichard A; Guignard R; Michels D; Beck F; Arwidson P; Lert F; Roy E
    Drug Alcohol Depend; 2013 Nov; 133(1):254-61. PubMed ID: 23726980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which illicit drugs are injected in Oslo? A study based on analysis of drug residues in used injection equipment and self-reported information.
    Gjerde H; Bretteville-Jensen AL; Bache-Andreassen L; Hanoa K; Furuhaugen H; Brochmann GW; Vindenes V
    Scand J Public Health; 2023 Feb; 51(1):21-27. PubMed ID: 34538164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clean needles save lives. HIV and injecting drug use.
    James B
    AIDS Action; 1993; (21):4-5. PubMed ID: 12345208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fast and highly selective LC-MS/MS screening for THC and 16 other abused drugs and metabolites in human hair to monitor patients for drug abuse.
    Koster RA; Alffenaar JW; Greijdanus B; VanDernagel JE; Uges DR
    Ther Drug Monit; 2014 Apr; 36(2):234-43. PubMed ID: 24071815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of drugs of abuse and some stimulants in hair samples by liquid chromatography-electrospray ionization ion trap mass spectrometry.
    Bucelli F; Fratini A; Bavazzano P; Comodo N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Dec; 877(31):3931-6. PubMed ID: 19864191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A snapshot of injecting drug consumption from the analysis of used syringes within the Medically Supervised Injecting Centre in Sydney, Australia.
    Fursman H; Finch E; Xiao L; Lefrançois E; Gupta A; Bartlett M; Latimer J; Chadwick S; Roux C; Morelato M
    Drug Alcohol Rev; 2024 Mar; 43(3):787-798. PubMed ID: 38145366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.